| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/01/2008 | EP1974016A2 Mesenchymal stem cells and uses therefor |
| 10/01/2008 | EP1973947A2 Immunoconjugates with improved efficacy for the treatment of diseases |
| 10/01/2008 | EP1973911A2 Azaindoles useful as inhibitors of janus kinases |
| 10/01/2008 | EP1973884A2 Novel heterocycles |
| 10/01/2008 | EP1973608A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 10/01/2008 | EP1973547A1 Compounds having cytokine modulating properties |
| 10/01/2008 | EP1608368B1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd) |
| 10/01/2008 | EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 10/01/2008 | EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof |
| 10/01/2008 | CN101277712A The composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 10/01/2008 | CN101277697A Dermatitis remedies |
| 10/01/2008 | CN101277687A Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 10/01/2008 | CN101274963A Anti-CD86 humanized monoclonal antibody |
| 10/01/2008 | CN101274962A Antibodies against human IL-12 |
| 10/01/2008 | CN101274077A Medicament composition for curing children's anorexia and preparation thereof |
| 10/01/2008 | CN101274008A Sustained-release dropping pill of Tripterygium glycosides and method of preparing the same |
| 10/01/2008 | CN101273999A Jinhuakui products and uses thereof |
| 10/01/2008 | CN101273993A Mometasone furoate solution type liquid preparation |
| 10/01/2008 | CN101273774A Bitter-buckwheat tea and preparation method thereof |
| 10/01/2008 | CN101273773A Health-care Chinese herbal medicine seasoning sauces |
| 10/01/2008 | CN100422322C Foot and mouth disease virus vaccine |
| 10/01/2008 | CN100422213C Therapeutic binding molecules |
| 10/01/2008 | CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/01/2008 | CN100422161C Hydroxymorpholinone derivative and medicinal use thereof |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100422139C 氨基链烷醇衍生物 Amino alkanol derivative |
| 10/01/2008 | CN100421727C Methods |
| 09/30/2008 | US7429666 Pyridine analogs as C5a antagonists |
| 09/30/2008 | US7429648 IREN protein, its preparation and use |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429602 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 09/30/2008 | US7429595 Inhibiting cyclin-dependent kinase complexes including cdk1/cyclin B, cdk2/cyclin E and cdk4/cyclin D1; preventing apoptosis |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429562 Form a clear microemulsion upon contact with an aqueous medium; preconcentrates; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, emulsifier, and ethanol |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/30/2008 | CA2626625A1 Intranasal drug delivery system |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2295604C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 09/30/2008 | CA2259140C Method of activating dendritic cells |
| 09/25/2008 | WO2008116160A1 Use of umbilical cord matrix cells |
| 09/25/2008 | WO2008116157A2 Mesenchymal stem cells and uses therefor |
| 09/25/2008 | WO2008116149A2 Apoptotic anti- ige antibodies binding the membrane-bound ige |
| 09/25/2008 | WO2008116064A2 Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 09/25/2008 | WO2008115920A2 Methods for the preparation and formulation of l-carnitine valproate salts |
| 09/25/2008 | WO2008115919A2 Methods for the preparation, formulation and use of lithium valproate |
| 09/25/2008 | WO2008115631A2 Plant-produced compositions for treating papillomavirus infection and related methods |
| 09/25/2008 | WO2008115259A2 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| 09/25/2008 | WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114553A1 Allergen inactivator |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008114516A1 Liposome and immunostimulating composition comprising the same |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114157A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 09/25/2008 | WO2008114008A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators |
| 09/25/2008 | WO2008114006A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 09/25/2008 | WO2008113881A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008080128B1 Devices and methods for inhibiting fibrosis |
| 09/25/2008 | WO2008054603A3 Il-17 receptor a antigen binding proteins |
| 09/25/2008 | WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 09/25/2008 | WO2008002449A3 Glycomimetic inhibitors of siglec-8 |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234382 Methods for the preparation, formulation and use of lithium valproate |
| 09/25/2008 | US20080234378 Methods for the preparation and formulation of l-carnitine valproate salts |
| 09/25/2008 | US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234294 Administering compounds such as 1,3-Dicyclohexyl-2-(5,6-dihydro-imidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea for therapy of Warts Hypogammaglobulinemia Immunideficiency Myelokathexis; neutropenia, hypogammaglobulinemia or HPV infection |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234251 8-Substituted Benzoazepines as Toll-Like Receptor Modulators |
| 09/25/2008 | US20080234242 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound |
| 09/25/2008 | US20080234212 siRNA molecules which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234178 Administering a mixture including a cell delivery agent and a cell death agent; reduced the level of the Bcl-2 antagonist protein Bim present in rheumatoid arthritis synovial tissue |
| 09/25/2008 | US20080233599 Immunogenic glycopeptides, screening, preparation and uses |
| 09/25/2008 | US20080233181 Nanoparticle adjuvants for sub-unit vaccines |
| 09/25/2008 | US20080233155 Bifidobacterium or Lactobacillus plantarum and/or combination of a corticosteroid with vitamin D3; autoimmune disease |
| 09/25/2008 | US20080233153 Vaccine compositions and adjuvant |
| 09/25/2008 | US20080233148 Method of Producing Virus |
| 09/25/2008 | US20080233144 Use of the Mushroom Agaricus Blazei Murill for the Production of Medicaments Suitable for Treating Infections and Allergies |
| 09/25/2008 | US20080233140 Binding Dectin-1 on immune cells with anti-Dectin-1-specific antibodies; rAb proteins; antigen presentation and immune cell activation; vaccines |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233137 Block the inflammatory and immunomodulatory activity mediated by endogenous C5a; Adult Respiratory Distress Syndrome (ARDS), severe tissue damage following thrombotic events such as heart attacks and stroke, inflammatory bowel diseases and rheumatoid arthritis |
| 09/25/2008 | US20080233136 Biologically Active Peptides |
| 09/25/2008 | US20080233134 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/25/2008 | US20080233132 Immunotherapy with myelin repair; immunoglobulins; autoimmune disorders |
| 09/25/2008 | US20080233131 Vaccine |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233118 Macrophage colony stimulating factor (M-Csf); monoclonal antibodies; atherosclerosis, HIV; kits |